Journals / European Journal of Rheumatology / 2017 / Cilt: 4 - Sayı: 4

Behçet’s disease in the United States: A single center descriptive and comparative study

Pages
239–244
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Using ICBDcriteria in the United States significantly increases the likelihood of identifying Behçet’s disease, particularly in patients with isolated mucosal involvement who constitute a substantial subset of patientsin this region.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Behçet’s disease is heterogeneous with clinical variability across ethnicities and geographiclocations.
📊
Key Findings & Data:Differences in disease characteristics between men and women, and between patients fulfilling the International Criteria for Behçet’s Disease (ICBD) and the International Study Group criteria (ISG) were determined in our cohort.Results: A total of 114 patients with a male to female ratio of ~ 1:4 were included.
💡
Conclusion & Impact:Using ICBDcriteria in the United States significantly increases the likelihood of identifying Behçet’s disease, particularly in patients with isolated mucosal involvement who constitute a substantial subset of patientsin this region.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Behçet’s disease is heterogeneous with clinical variability across ethnicities and geographiclocations. The goal of this study was to analyze the clinical characteristics of our multi-ethnic Behçet’sdisease cohort at the University of Michigan.Material and Methods: A detailed patient characterization was performed. Differences in disease characteristics between men and women, and between patients fulfilling the International Criteria for Behçet’s Disease (ICBD) and the International Study Group criteria (ISG) were determined in our cohort.Results: A total of 114 patients with a male to female ratio of ~ 1:4 were included. All patients met theICBD criteria, including 76 who also met the ISG criteria. Over 95% of patients had recurrent genitalulcers, which is higher than generally reported. Retinitis was 5.3 times more likely in men than inwomen (p=0.009), and arthralgia was 3.3 times more likely in women than men (p=0.048). Whencomparing cohorts derived from the two different criteria, the ISG cohort had more skin manifestations (OR=3.3, p=0.0006). Acneiform lesions were associated with ~8 times higher odds of developingretinitis in our patients (p=0.0008), and superficial thrombophlebitis was associated with a trend forhigher odds of developing uveitis (OR=4.1, p=0.057). Using the ICBD criteria, 38 additional patientswere identified compared to only using the ISG criteria. Of these patients, 28 presented with onlymucosal ulceration with or without joint involvement.Conclusion: We characterize Behçet’s disease in a multi-ethnic cohort from North America. Using ICBDcriteria in the United States significantly increases the likelihood of identifying Behçet’s disease, particularly in patients with isolated mucosal involvement who constitute a substantial subset of patientsin this region.

🔖

Cite This Article

KİLİAN, N. C., SAWALHA, A. H. (2022). Behçet’s disease in the United States: A single center descriptive and comparative study. European Journal of Rheumatology, Cilt: 4 - Sayı: 4, 239–244. https://ajindex.com/articles/511734

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990; 335: 1078-80
  2. International Team for the Revision of the International Criteria for Behcet's D. The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014; 28: 338-47
  3. Ahmed Z, Rossi ML, Yong S, Martin DK, Walayat S, Cashman M, et al. Behcet's disease departs the 'Silk Road': a case report and brief review of literature with geographical comparison. J Community Hosp Intern Med Perspect 2016; 6: 30362. [CrossRef] 4. Yurdakul S, Hamuryudan V, Yazici H. Behcet syndrome. Curr Opin Rheumatol 2004; 16: 38-42. [CrossRef ] 5. Chang HK, Kim JW. The clinical features of Behcet's disease in Yongdong districts: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci 2002; 17: 784-9. [CrossRef ] 6. Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, et al. Comparison of patients with Behcet's disease in the 1980s and 1990s. Ophthalmology 2004; 111: 810-5. [CrossRef] 7. Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A. Clinical features of chinese patients with Behcet's disease. Ophthalmology 2008; 115: 312-8. [CrossRef ] 8. Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005; 30: 943-8. [CrossRef ] 9. Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behcet's disease in the US: a population-based study. Arthritis Rheum 2009; 61: 600-4. [CrossRef ] 10. Sibley C, Yazici Y, Tascilar K, Khan N, Bata Y, Yazici H, et al. Behcet syndrome manifestations and activity in the United States versus Turkey -- a cross-sectional cohort comparison. J Rheumatol 2014; 41: 1379-84. [CrossRef ] 11. Sarica-Kucukoglu R, Akdag-Kose A, Kayabal IM, Yazganoglu KD, Disci R, Erzengin D, et al. Vascular involvement in Behcet's disease: a retrospective analysis of 2319 cases. Int J Dermatol 2006; 45: 919-21. [CrossRef ] 12. Dervis E, Geyik N. Sensitivity and specificity of different diagnostic criteria for Behcet's disease in a group of Turkish patients. J Dermatol 2005; 32: 266-72. [CrossRef ] 13. Yilmaz S, Karadag O, Yazisiz V, Altun B, Gezer M, Karaman M, et al. Systemic involvements and preferred treatments in a large cohort of Behcet's disease. Rheumatol Int 201